期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

多囊卵巢综合征与胰岛素抵抗

Polycystic ovary syndrome and insulin resistance
原文传递
导出
摘要 多囊卵巢综合征（PCOS）是育龄妇女常见的内分泌失调性疾病。胰岛素抵抗是其发生、发展的重要病理生理机制。近年来，PCOS患者胰岛素抵抗具体的分子机制得到了深入研究，涉及胰岛素的分泌、代谢和各种脂肪因子等。本文即对PCOS患者胰岛素抵抗分子机制的研究进展作一综述。 Polycystic ovary syndrome （PCOS） is one of the most common endocrine disorder of women in reproductive age. Insulin resistance （IR） plays a key role in the development of PCOS. The secretion and metabolism of insulin and adipokines are related to the molecular mechanism of IR in PCOS. This review focuses on the recent progress of this aspect.
作者 毛秀英 陶弢 刘伟
机构地区 上海交通大学医学院仁济医院内分泌代谢病科
出处 《国际内分泌代谢杂志》 2009年第B04期66-68,共3页 International Journal of Endocrinology and Metabolism
基金 上海市科学技术委员会科研项目（08411953000）
关键词 胰岛素抵抗 多囊卵巢综合征 分子机制 Insulin resistance Polycystic ovary syndrome Molecular mechanism
分类号 R711.75 [医药卫生—妇产科学] R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献15

  • 1Diamanti-Kandarakis E, Piperi C, Spina J, et al. Polycystic ovary syndrome: the influence of environmental and genetic factors. Hormones (Athens) ,2006,5 : 17-34.
  • 2Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril,2002,77:1095-1105.
  • 3Calvo RM ,Telleria D, Sancho J, et al. Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women. Fertil Steril,2002,77 : 666-668.
  • 4Wang KH, You L, Shi YH, et al. Association of genetic variants of insulin degrading enzyme with metabolic features in women with polycystic ovary syndrome. Fertil Steril,2008 ,90 :378-384.
  • 5Mor E, Zograbyan A, Saadat P, et al. The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis. Am J Obstet Gyneco1,2004,190 : 1654-1660.
  • 6Hφjlundl K,Glintborgl D,Andersen NR,et al. Impaired insulinstimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polyeystic ovary syndrome is reversed by pioglitazone treatment. Diabetes,2008,57:357-366.
  • 7Michelle R, Jones BS, Wilson SG, et al. Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome. Fertil Steril,2008 ,90 :2298-2303.
  • 8Seow KM,Juan CC ,Wu LY,et al. Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance. Hum Reprod, 2004,19:48-53.
  • 9Salehi M, Bravo-Vera R, Sheikh A, et al. Pathogenesis of polycystic ovary syndrome: what is the role of obesity? Metabolism, 2004,53:358-376.
  • 10Sepilian V, Nagamani M. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. J Soc Gynecol Investig,2005,12 : 129-134.

二级参考文献8

  • 1Salehi M, Bravo-Vera R, Sheikh A, et al. Pathogenesis of polycystic ovary syndrome: what is the role of obesity? [ J ] Metabolism ,2004,53:358-376.
  • 2Dunaif A ,Thomas A. Current concepts in the polycystic ovary syndrome[ J]. Annu Rev Med,2001,52:401-419.
  • 3Dunaif A. Insulin resistance in women with polycystic ovary syndrome [ J ]. Fertil Steril,2006,86 : S13-14.
  • 4Goodarzi MO, Erickson S, Port SC, et al. Relative impact of insulin resistance and obesity on cardiovascular risk factors in polycystic ovary syndrome [ J ]. Metabolism, 2003, 52:713-719.
  • 5Sepilian V, Nagamani M. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance [ J ]. J Soc Gynecol Investig, 2005,12 : 129-134.
  • 6Panidis D, Kourtis A, Farmakiotis D, et al. Serum adiponectin levels in women with polycystic ovary syndrome [ J ]. Hum Reprod ,2003,18 : 1790-1796.
  • 7Sieminska L, Marek B, Kos-Kudla B, et al. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters [ J ]. J Endocrinol Invest,2004,27:528-534.
  • 8Ardawi MS, Rouzi AA. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome [ J ]. Fertil Steril,2005,83 : 1708-1716.

共引文献6

国际内分泌代谢杂志
2009年 第B04期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部